Statistics in preclinical pharmaceutical research and development

被引：0

作者：

Gunter, B ^{[1
]}

Holder, D

机构：

[1] Merck Res Labs, Princeton, NJ 08540 USA

[2] Merck Res Labs, West Point, PA 19486 USA

来源：

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION | 2000年 / 95卷 / 451期

关键词：

D O I：

10.2307/2669485

中图分类号：

O21 [概率论与数理统计]; C8 [统计学];

学科分类号：

020208 ; 070103 ; 0714 ;

摘要：

引用

页码：998 / 1001

页数：4

共 50 条

[21] Ramucirumab: preclinical research and clinical development
Aprile, Giuseppe
Rijavec, Erika
Fontanella, Caterina
Rihawi, Karim
Grossi, Francesco
ONCOTARGETS AND THERAPY, 2014, 7 : 1997 - 2006
[22] The determinants of pharmaceutical research and development expenditures
Henry Grabowski
John Vernon
Journal of Evolutionary Economics, 2000, 10 : 201 - 215
[23] Assessing Pharmaceutical Research and Development Costs
DiMasi, Joseph A.
JAMA INTERNAL MEDICINE, 2018, 178 (04) : 587 - 587
[24] Nonprofit organizations and pharmaceutical research and development
Moos, Walter H.
Collins, Nathan
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[25] Applications of proteomics in pharmaceutical research and development
Yokota, Hiroyuki
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2019, 1867 (01): : 17 - 21
[26] PLANNING MODEL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
COX, JSG
MILLANE, BV
STYLES, AEJ
R & D MANAGEMENT, 1975, 5 (03) : 219 - 227
[27] The determinants of pharmaceutical research and development expenditures
Grabowski, H
Vernon, J
JOURNAL OF EVOLUTIONARY ECONOMICS, 2000, 10 (1-2) : 201 - 215
[28] TENDENCIES AND PROSPECTS IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT
NOWOTNY, OH
FORTSCHRITTE DER MEDIZIN, 1978, 96 (18) : 939 - &
[29] The Role of Marketing in Pharmaceutical Research and Development
John E. Calfee
PharmacoEconomics, 2002, 20 : 77 - 85
[30] TENDENCIES AND PROSPECTS IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT
NOWOTNY, OH
FORTSCHRITTE DER MEDIZIN, 1978, 96 (12) : 615 - 616

← 1 2 3 4 5 →